Venus Concept Inc. (VERO)
NASDAQ: VERO · Real-Time Price · USD
0.409
-0.025 (-5.82%)
Nov 5, 2024, 3:49 PM EST - Market open
Venus Concept Employees
Venus Concept had 304 employees as of December 31, 2023. The number of employees decreased by 80 or -20.83% compared to the previous year.
Employees
304
Change (1Y)
-80
Growth (1Y)
-20.83%
Revenue / Employee
$229,635
Profits / Employee
-$164,240
Market Cap
2.97M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Regional Health Properties | 114 |
MSP Recovery | 88 |
iSpecimen | 53 |
Scinai Immunotherapeutics | 31 |
ReShape Lifesciences | 29 |
InMed Pharmaceuticals | 13 |
TNF Pharmaceuticals | 6 |
Avenue Therapeutics | 3 |
VERO News
- 4 weeks ago - Venus Concept to Release Third Quarter of Fiscal Year 2024 Financial Results on November 13, 2024 - GlobeNewsWire
- 5 weeks ago - Venus Concept Announces $15 million Debt-to-Equity Exchange Transaction - GlobeNewsWire
- 6 weeks ago - Venus Concept Announces Australian Regulatory Approval for Venus Bliss MAX - GlobeNewsWire
- 3 months ago - Venus Concept Inc. (VERO) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Venus Concept Announces Second Quarter of Fiscal Year 2024 Financial Results - GlobeNewsWire
- 3 months ago - Venus Concept Announces Regulatory Approval for Venus Bliss MAX in Canada - GlobeNewsWire
- 4 months ago - Venus Concept to Release Second Quarter of Fiscal Year 2024 Financial Results on August 13, 2024 - GlobeNewsWire
- 4 months ago - Venus Concept Celebrates Successful Completion of its NEXThetics Events Across North America - GlobeNewsWire